通化东宝：截至2025年10月17日前十大流通股东持股占比47.97%

Group 1 - Company announced a share buyback plan to be approved at the board meeting on October 17, 2025 [1] - The top ten unrestricted shareholders hold approximately 9.4 billion shares, accounting for 47.97% of total shares [1] - Major shareholders include Dongbao Industrial Group with about 614 million shares (31.34%) and Tianjin Zhenyi Equity Investment Partnership with about 183 million shares (9.35%) [1] Group 2 - For the first half of 2025, the company's revenue composition shows that the pharmaceutical industry accounts for 98.59%, while other businesses and real estate account for 1.27% and 0.14% respectively [2] - The current market capitalization of the company is 17.2 billion yuan [2]